502 filings
Page 7 of 26
SC 13G
CVI Investments, Inc.
15 Jan 21
ATOSSA THERAPEUTICS / CVI Investments ownership change
11:42am
SC 13G/A
CVI Investments, Inc.
15 Jan 21
ATOSSA THERAPEUTICS / CVI Investments ownership change
11:41am
SC 13G
ATOS
Atossa Therapeutics Inc
14 Jan 21
ATOSSA THERAPEUTICS / Empery Asset Management ownership change
9:00am
424B3
ATOS
Atossa Therapeutics Inc
8 Jan 21
Prospectus supplement
9:15am
8-K
ATOS
Atossa Therapeutics Inc
8 Jan 21
Entry into a Material Definitive Agreement
9:00am
SC 13G
Intracoastal Capital, LLC
28 Dec 20
ATOSSA THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:14am
424B5
ATOS
Atossa Therapeutics Inc
21 Dec 20
Prospectus supplement for primary offering
9:16am
8-K
ATOS
Atossa Therapeutics Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:10am
SC 13G
CVI Investments, Inc.
18 Dec 20
ATOSSA THERAPEUTICS / CVI Investments ownership change
12:01pm
8-K
ATOS
Atossa Therapeutics Inc
14 Dec 20
Entry into a Material Definitive Agreement
4:16pm
424B3
ATOS
Atossa Therapeutics Inc
11 Dec 20
Prospectus supplement
7:28am
EFFECT
ATOS
Atossa Therapeutics Inc
9 Dec 20
Notice of effectiveness
12:15am
8-K
ATOS
Atossa Therapeutics Inc
8 Dec 20
Financial Statements and Exhibits
4:30pm
CORRESP
ATOS
Atossa Therapeutics Inc
7 Dec 20
Correspondence with SEC
12:00am
CORRESP
ATOS
Atossa Therapeutics Inc
7 Dec 20
Correspondence with SEC
12:00am
S-1/A
ATOS
Atossa Therapeutics Inc
IPO registration (amended)
1 Dec 20
5:31pm
8-K
ATOS
Atossa Therapeutics Inc
30 Nov 20
Other Events
8:30am
UPLOAD
ATOS
Atossa Therapeutics Inc
27 Nov 20
Letter from SEC
12:00am
S-1
ATOS
Atossa Therapeutics Inc
IPO registration
20 Nov 20
4:26pm
10-Q
2020 Q3
ATOS
Atossa Therapeutics Inc
Quarterly report
13 Nov 20
9:31am